Timothy W Schacker
Overview
Explore the profile of Timothy W Schacker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
78
Citations
8124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Basting C, Langat R, Broedlow C, Guerrero C, Bold T, Bailey M, et al.
Microbiol Spectr
. 2024 Sep;
12(11):e0068024.
PMID: 39345212
Coronavirus disease 2019 (COVID-19) and its associated severity have been linked to uncontrolled inflammation and may be associated with changes in the microbiome of mucosal sites including the gastrointestinal tract...
2.
Miller J, Rhein J, Davis Z, Cooley S, McKenna D, Anderson J, et al.
J Infect Dis
. 2024 Jan;
229(5):1256-1265.
PMID: 38207119
Background: Natural killer (NK) cells are dysfunctional in chronic human immunodeficiency virus (HIV) infection as they are not able to clear virus. We hypothesized that an infusion of NK cells,...
3.
Wietgrefe S, Anderson J, Duan L, Southern P, Zuck P, Wu G, et al.
J Clin Invest
. 2023 Sep;
133(22).
PMID: 37733443
Productively infected cells are generally thought to arise from HIV infection of activated CD4+ T cells, and these infected activated cells are thought to be a recurring source of latently...
4.
Schifanella L, Anderson J, Wieking G, Southern P, Antinori S, Galli M, et al.
J Infect Dis
. 2023 Mar;
227(11):1245-1254.
PMID: 36869698
Alveolar type II (ATII) pneumocytes as defenders of the alveolus are critical to repairing lung injury. We investigated the ATII reparative response in coronavirus disease 2019 (COVID-19) pneumonia, because the...
5.
Lima N, Musayev M, Johnston T, Wagner D, Henry A, Wang L, et al.
Nat Commun
. 2022 Dec;
13(1):7733.
PMID: 36517467
An important consequence of infection with a SARS-CoV-2 variant is protective humoral immunity against other variants. However, the basis for such cross-protection at the molecular level is incompletely understood. Here,...
6.
Schifanella L, Anderson J, Wieking G, Southern P, Antinori S, Galli M, et al.
bioRxiv
. 2022 Aug;
PMID: 35982650
Graphic: Highlights: In fatal COVID-19 pneumonia, the initial destruction of Type II alveolar cells by SARS-CoV-2 infection is amplified by infection of the large numbers of spatially contiguous Type II...
7.
Wietgrefe S, Duan L, Anderson J, Marques G, Sanders M, Cummins N, et al.
J Virol
. 2022 Jul;
96(15):e0088522.
PMID: 35856674
Anti-retroviral therapy (ART) generally suppresses HIV replication to undetectable levels in peripheral blood, but immune activation associated with increased morbidity and mortality is sustained during ART, and infection rebounds when...
8.
Pape K, Dileepan T, Matchett W, Ellwood C, Stresemann S, Kabage A, et al.
JCI Insight
. 2022 Jun;
7(12).
PMID: 35730567
Immunosuppressed patients with inflammatory bowel disease (IBD) generate lower amounts of SARS-CoV-2 spike antibodies after mRNA vaccination than healthy controls. We assessed SARS-CoV-2 spike S1 receptor binding domain-specific (S1-RBD-specific) B...
9.
Lima N, Musayev M, Johnston T, Wagner D, Henry A, Wang L, et al.
bioRxiv
. 2022 Apr;
PMID: 35378757
An important consequence of infection with a SARS-CoV-2 variant is protective humoral immunity against other variants. The basis for such cross-protection at the molecular level is incompletely understood. Here we...
10.
Puskarich M, Ingraham N, Merck L, Driver B, Wacker D, Black L, et al.
JAMA Netw Open
. 2022 Mar;
5(3):e222735.
PMID: 35294537
Importance: SARS-CoV-2 viral entry may disrupt angiotensin II (AII) homeostasis, contributing to COVID-19 induced lung injury. AII type 1 receptor blockade mitigates lung injury in preclinical models, although data in...